Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 17 LLY Top Research Reports for Microsoft, Eli Lilly & Costco
May 17 IONS Ionis, Biogen Down on Ending Development of ALS Drug
May 17 LLY 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
May 17 LLY Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
May 17 LLY Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
May 17 MRK 5 Stocks Powering the Dow ETF Year to Date
May 17 IONS Ionis (IONS), Biogen Down on Ending Development of ALS Drug
May 17 INBS Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety Event
May 17 LLY Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk
May 17 LLY Eli Lilly’s efsitora alfa shows promise in Phase III T2D trials
May 17 LLY Zacks Investment Ideas feature highlights: Apple, Eli Lilly and Crocs
May 16 LLY 3 Stocks to Buy Following Positive Earnings Results
May 16 HALO Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
May 16 IONS Biogen also drops collaboration with Ionis on Angelman syndrome candidate
May 16 MRK Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
May 16 LLY 3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
May 16 LLY Roche’s New Weight-Loss Data Shows Lilly Isn’t Unbeatable in Obesity
May 16 HALO Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock
May 16 LLY Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
May 16 MRK Merck (MRK) Crossed Above the 20-Day Moving Average: What That Means for Investors
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags